Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion-Reference-Cited by-同舟云学术

Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion

Published:2017-06 Issue:6 Volume:19 Page:689-702
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Kaartinen Tanja,Luostarinen Annu,Maliniemi Pilvi,Keto Joni,Arvas Mikko,Belt Heini,Koponen Jonna,Loskog Angelica,Mustjoki Satu,Porkka Kimmo,Ylä-Herttuala Seppo,Korhonen Matti

Funder

VTR State Research Funding for Finnish Red Cross Blood Service

Pediatric Research Foundation

Noona and Kullervo Väre Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference42 articles.

1. Adoptive immunotherapy for cancer or viruses;Maus;Annu Rev Immunol,2014

2. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin Cancer Res,2011

3. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma;Rapoport;Nat Med,2015

4. CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies;Turtle;Clin Pharmacol Ther,2016

5. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy;Robbins;J Immunol,2004

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated perspective on measuring cytokines to inform CAR-T bioprocessing;Biotechnology Advances;2024-10

2. Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing;Cytotherapy;2024-09

3. Potential applications of macrophages in cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-09

4. Ex vivo T cell differentiation in adoptive immunotherapy manufacturing: Critical process parameters and analytical technologies;Biotechnology Advances;2024-08

5. Generation of CAR-TSCM: CAR-T with super clutch;International Immunopharmacology;2024-07